Certified by Founder Lodge
Versant Ventures
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $142,000,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology c
| Company | Date | Round | Raised |
|---|---|---|---|
Light Horse Therapeutics |
January, 10 ,2025 | Series A | $62,000,000 |
Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
AllRock Bio |
September, 17 ,2025 | Series A | $50,000,000 |
Kate Therapeutics |
June, 08 ,2023 | Series A | $51,000,000 |
Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
Santa Ana Bio, Inc. |
June, 14 ,2024 | Series A | $168,000,000 |
858 Therapeutics |
September, 27 ,2024 | Series B | $50,000,000 |
Light Horse Therapeutics |
January, 10 ,2025 | Series A | $62,000,000 |
AllRock Bio |
September, 17 ,2025 | Series A | $50,000,000 |
Light Horse Therapeutics
Abdera Therapeutics
AllRock Bio
Kate Therapeutics
Gate Bioscience
Santa Ana Bio, Inc.
858 Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Clairity, Inc. | $43,000,000 | (Nov 14, 2025)
Songscription | $5,000,000 | (Nov 14, 2025)
Park Loyalty | Undisclosed Amount | (Nov 14, 2025)
Carbon(US) | $60,000,000 | (Nov 14, 2025)
CoRun.ai | $3,500,000 | (Nov 14, 2025)